NADH is the body’s primary electron shuttle, ferrying the chemical energy extracted from food into the machinery that produces the vast majority of your cellular fuel. Without it, the metabolic chain that converts glucose and fats into usable energy grinds to a halt. But NADH does far more than power your cells: its balance with its oxidized partner, NAD+, influences everything from how you age to how well you sleep, and disruptions to that balance show up in obesity, diabetes, neurodegeneration, and cancer.
From Food to Fuel
Every time you eat, your body breaks down carbohydrates, fats, and proteins into smaller molecules. Along the way, enzymes strip hydrogen atoms from those molecules and load them onto a carrier called NAD+, converting it into NADH. This happens during multiple stages of metabolism, but the heavy lifting occurs in the mitochondria, the compartments inside your cells dedicated to energy production. NAD+ and its reduced form NADH are active versions of vitamin B3, and they are essential for energy metabolism, cell protection, and biosynthesis.1PubMed Central. NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy
NADH’s job, once loaded with electrons, is to deliver them to a specific destination: the electron transport chain, a series of protein complexes embedded in the inner mitochondrial membrane. There, the electrons cascade through a sequence of handoffs, and the energy released at each step is used to pump protons across the membrane. That proton gradient ultimately drives the production of ATP, the molecule your cells spend as energy currency. A single molecule of glucose can yield around 30 to 32 ATP through this process, and most of that yield depends on NADH delivering its cargo to the first stop in the chain.
The Entry Point for Electrons
The first protein complex that accepts NADH’s electrons is called complex I, formally known as NADH:ubiquinone oxidoreductase. It is the largest component of the electron transport chain and, despite decades of study, still the least fully understood.2PubMed Central. Mitochondrial respiratory complex I: structure, function and implication in human diseases Complex I accepts electrons from NADH, passes them along to a small lipid-soluble carrier called ubiquinone, and uses the energy from that transfer to pump protons out of the mitochondrial interior. When complex I is working properly, this is seamless. When it is not, the consequences are severe: electrons can leak out and react with oxygen to form damaging reactive oxygen species, and the whole energy-production pipeline slows down.
Toxins that block complex I illustrate how critical this step is. Rotenone, a pesticide found in certain plants, inhibits complex I directly. In laboratory studies, rotenone exposure caused dose-dependent increases in oxidative damage and depleted cellular defenses against that damage.3Journal of Neuroscience. Mechanism of Toxicity in Rotenone Models of Parkinson’s Disease Researchers use rotenone to model Parkinson’s disease in animals precisely because blocking the point where NADH feeds into the respiratory chain reproduces many features of the disease, including the death of dopamine-producing neurons.
Why the Ratio Matters More Than the Amount
Biologists rarely talk about NADH or NAD+ in isolation. What matters most is the ratio between them. The NAD+/NADH balance acts as a kind of metabolic thermostat, and these two redox couples are essential for maintaining the cell’s overall redox equilibrium and modulating a wide range of biological processes.4PubMed Central. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism When the ratio tips too far in either direction, cells struggle to function normally.
A high NAD+/NADH ratio signals that the cell has plenty of oxidizing capacity and is ready to accept more electrons from metabolic reactions. A low ratio, meaning relatively more NADH and less NAD+, signals that the electron transport chain is backed up or that the cell is flooded with fuel it cannot process fast enough. Shifts in this ratio can derail biological systems and contribute to neurodegenerative disorders, aging, and tumor formation.5PubMed Central. Role of NAD+ in regulating cellular and metabolic signaling pathways
This matters because NAD+ is not just a passive electron carrier. It is also consumed as a raw material by two important families of enzymes: sirtuins and PARPs. Sirtuins are involved in DNA repair, inflammation control, and metabolic regulation; PARPs help fix damaged DNA. Both families require NAD+ to function, and they compete with each other for the available supply.6PubMed Central. Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes When NADH accumulates and the ratio shifts, less NAD+ is available for these enzymes, and cell maintenance suffers.
NADH Overload and Metabolic Disease
One of the more consequential findings in recent metabolic research is that too much NADH, not too little, is a problem in several common diseases. The condition is sometimes called reductive stress, and it is increasingly recognized as a mirror image of the better-known oxidative stress. In obesity, an elevated NADH/NAD+ ratio in the liver has been linked to insulin resistance and increased production of fat and glucose.7PubMed Central. Reductive stress-a common metabolic feature of obesity and cancer The mechanism is straightforward in principle: when you chronically overload cells with more fuel than they can burn, the electron carriers pile up in their reduced form, and the ratio tilts.
Chronic high insulin levels and insulin resistance make this worse by increasing glucose flow into cells and ramping up pathways that generate even more reducing equivalents. This persistent over-reduction disrupts mitochondrial function and metabolic flexibility.8PubMed Central. Reductive Stress and Ferroptosis: Linking Insulin Signaling to Metabolic Dysfunction The cell loses its ability to toggle smoothly between burning fat and burning sugar, a hallmark of metabolic health.
A landmark study demonstrated that NADH reductive stress in the liver underlies the effects of a common genetic variant on multiple metabolic traits, including circulating triglyceride levels, glucose tolerance, and FGF21 levels.9Nature. Hepatic NADH reductive stress underlies common variation in metabolic traits That is, the same NADH imbalance connected genetically diverse metabolic problems that had previously seemed unrelated. It is one of the clearer demonstrations that the NAD+/NADH ratio is not just a biochemical detail but a central organizing feature of metabolic health.
The Age-Related Decline
NAD+ levels drop as you get older. This has been confirmed across multiple tissues in animal studies and in human observational data, and it is now considered one of the better-established molecular features of aging. A key driver of this decline appears to be the enzyme CD38, whose expression and activity increase with age. In mice, CD38 was required for the age-related NAD decline and the resulting mitochondrial dysfunction, operating through a pathway that includes the sirtuin SIRT3.10PubMed Central. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
The practical implication is that aging cells get caught in a feedback loop: CD38 activity rises, NAD+ levels fall, sirtuin activity drops, mitochondria malfunction, and energy production declines. In genetically engineered mice lacking CD38, NAD+ levels remained stable during aging and the decline in mitochondrial function was forestalled.11Cell Metabolism. The NADase CD38 Dictates the Age-Related NAD Decline and Mitochondrial Dysfunction This does not mean CD38 is the whole story of aging, but it identifies one concrete mechanism through which NAD+ depletion and mitochondrial decay are connected.
The same NAD+ biosynthesis pathway has been implicated in the age-related decline of pancreatic beta cell function, a key contributor to the development of type 2 diabetes. The enzyme NAMPT, which is the rate-limiting step in one of the body’s main routes for making NAD+, works with SIRT1 to regulate insulin secretion, and reductions in this pathway may contribute to diabetes risk as people age.12PubMed Central. Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes
Cellular Aging in the Lab
The aging pattern is not limited to whole organisms. When human mesenchymal stem cells were expanded in culture, their intracellular NAD+ levels progressively declined while NADH levels climbed, resulting in a lower NAD+/NADH ratio in older-passage cells compared to younger ones.13Communications Biology. NAD+/NADH redox alterations reconfigure metabolism and rejuvenate senescent human mesenchymal stem cells in vitro Restoring the ratio in these experiments rejuvenated some features of the senescent cells, suggesting that the redox shift is not just a byproduct of aging but a causal factor. This finding echoes the animal data and gives researchers a tractable model for testing interventions aimed at correcting the imbalance.
Exercise Boosts Both Sides
If the NAD+/NADH ratio declines with age, one natural question is whether anything can push it back. Exercise appears to be one of the most reliable interventions, at least in muscle tissue. A study of middle-aged, overweight, previously untrained adults found that ten weeks of resistance training increased muscle NAD+ by about 127% and NADH by about 99%, alongside a 13% increase in global sirtuin activity.14PubMed Central. Resistance training increases muscle NAD+ and NADH concentrations as well as NAMPT protein levels and global sirtuin activity in middle-aged, overweight, untrained individuals The enzyme NAMPT, which drives NAD+ production, also rose by about 15%.
The fact that both NAD+ and NADH increased is important. Exercise does not simply tilt the ratio by reducing one side; it appears to expand the entire pool. Larger pools of both forms give cells more metabolic headroom, more capacity to shuttle electrons and more substrate for sirtuins and PARPs to use. The downstream effect on sirtuin activity is especially relevant given sirtuins’ roles in DNA repair and metabolic regulation, processes that decline with age.
Diet, Ketosis, and the Redox Ratio
Dietary interventions can also shift the NAD+/NADH balance, and the ketogenic diet is among the most studied in this context. Researchers have proposed that an increase in the NAD+/NADH ratio is a potential unifying mechanism behind the ketogenic diet’s documented benefits, which include seizure reduction in epilepsy and various metabolic improvements.15PubMed Central. A unifying mechanism of ketogenic diet action: The multiple roles of nicotinamide adenine dinucleotide
In healthy human volunteers, nutritional ketosis increased brain NAD+ by about 3.4%, decreased NADH by about 13%, and raised the NAD+/NADH ratio by roughly 18%, measured non-invasively using specialized brain imaging.16Frontiers in Nutrition. Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS These are modest changes, but given how tightly cells regulate redox balance, an 18% shift in the ratio is meaningful at the cellular level. It suggests that what you eat can directly influence the redox state deep inside your brain tissue, not just in peripheral organs.
Your Internal Clock Runs on NADH
The NAD+/NADH balance does not hold steady throughout the day. It oscillates in circadian patterns, rising and falling roughly in sync with the body’s 24-hour clock. NADH levels cycle with circadian rhythm in mammalian cells, and these oscillations provide a metabolic signal that couples the circadian clock to cellular metabolic states.17PubMed Central. Circadian Oscillations of NADH Redox State Using a Heterologous Metabolic Sensor in Mammalian Cells
The connection runs deeper than mere correlation. The core clock proteins CLOCK and BMAL1, which are transcription factors that drive circadian gene expression, are directly sensitive to the redox state of NAD cofactors. Reduced forms like NADH and NADPH strongly enhance the binding of these proteins to DNA, while the oxidized forms inhibit it.18PubMed. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors This raises a striking possibility: food and neuronal activity may directly entrain circadian rhythms by changing the cell’s redox state. If your NADH levels shift after a meal, that shift could nudge clock gene activity, linking meal timing to your body’s sense of what time it is. NAD+-dependent sirtuin enzymes act as integrators between these circadian and metabolic cycles, with implications for healthy aging.19PubMed Central. Circadian NAD(P)(H) cycles in cell metabolism
Gut Bacteria and the NAD Supply Chain
Your gut microbiome is a surprisingly active participant in NAD metabolism. Circulating nicotinamide, a form of vitamin B3, enters the gut lumen from the bloodstream and is used by intestinal bacteria to make their own NAD+. In the small intestine, host-derived nicotinamide accounts for the vast majority of microbial NAD synthesis, while in the colon about half of microbial NAD is synthesized from dietary fiber.20Cell Metabolism. A vitamin B3 cycle coordinates metabolic state between microbiome and host This is not a one-way street. Gut bacteria convert nicotinamide through a deamidation pathway that substantially contributes to the NAD-boosting effects of oral nicotinamide and nicotinamide riboside supplementation across several tissues.21Cell Metabolism. Bacteria Modify Mammalian Host NAD Metabolism by Consuming and Producing NAD Precursors
The practical implication is that the health and composition of your gut bacteria may influence how effectively oral NAD+ precursor supplements actually work. A person with a disrupted microbiome might get less of a boost from the same supplement dose, though this connection is still being worked out in humans.
NMN Supplements and the Gap Between Hype and Evidence
The supplement industry has seized on the age-related decline in NAD+ to market precursor molecules, particularly nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), as anti-aging interventions. NMN supplementation does reliably raise blood NAD+ levels. In a randomized, double-blind, placebo-controlled trial of healthy middle-aged adults, all NMN-treated groups showed significantly elevated blood NAD concentrations by day 30 and day 60, with improvements in a six-minute walking test compared to placebo and a stabilization of blood biological age markers that worsened in the placebo group.22PubMed Central. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
That sounds promising, but a systematic review with meta-analysis across randomized controlled trials reached a more cautious conclusion: while NMN supplementation reliably raised blood NAD levels, most clinically relevant outcomes were not significantly different between NMN and control groups, and the reviewers suggested that the benefits of NMN supplementation may be exaggerated in the field.23PubMed. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials The gap between raising NAD+ in the blood and producing meaningful health improvements is genuine, and it is where much of the current research is focused. Simply flooding the body with more NAD+ precursors does not guarantee that the additional NAD+ reaches the right tissues, enters the right compartments, or meaningfully shifts the ratio in cells that need it.
NADH and the Heart
During a heart attack, blood flow to part of the heart muscle is cut off, and the starved tissue switches to anaerobic metabolism, causing NADH to accumulate rapidly. Studies in intact hearts found that NADH roughly doubled during ischemia, though it returned to normal on initial reperfusion.24PubMed. Changes in Na(+), compartmental [Ca(2+)], and NADH with dysfunction after global ischemia in intact hearts The trouble is that the surge of NADH during the ischemic period appears to set up conditions for damage. Elevated NADH inhibits an enzyme called xanthine dehydrogenase, and when blood flow returns, the rebound can trigger a burst of reactive oxygen species. Experiments showed that substances that lowered the NADH/NAD ratio in a dose-dependent manner, such as pyruvate and aspartate, protected against tissue injury and improved contractile function after reperfusion.25International Journal of Cardiology. Metabolic modulation of cellular redox potential can improve cardiac recovery from ischemia–reperfusion injury
This is a case where NADH goes from being essential to being dangerous depending on context. Under normal oxygen supply, NADH is dutifully carrying electrons to the transport chain. Under oxygen deprivation, the same molecule piles up with nowhere to deliver its cargo, and the backed-up reducing power becomes part of the injury mechanism.
Cancer Cells and the NADH Bottleneck
Cancer cells face a peculiar NADH problem. Many rapidly growing tumors rely heavily on glycolysis even when oxygen is available, a phenomenon sometimes called the Warburg effect. This process generates NADH in the cytoplasm, and the cell needs to recycle it back to NAD+ to keep glycolysis running. One route for this recycling is lactate dehydrogenase, which converts pyruvate to lactate while regenerating NAD+. Research on acute myeloid leukemia cells found that this enzyme was essential not just for producing lactate but for maintaining a correct NAD+/NADH ratio, and without it the cells could not survive.26PubMed Central. Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival
Another route for managing cytoplasmic NADH is the malate-aspartate shuttle, which transfers reducing equivalents from the cytoplasm into the mitochondria. This shuttle is indispensable for supporting the high glycolytic rate that tumor cells need for rapid growth.27PubMed Central. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth Yet many proliferating cells discard reducing equivalents as lactate rather than shuttling them into mitochondria, and recent research indicates that aspartate availability is what determines how much of the shuttle gets used.28Molecular Cell. Aspartate availability drives differential engagement of the malate-aspartate shuttle This is an active area of cancer metabolism research, because disrupting a tumor’s ability to recycle NADH could starve it of the NAD+ it needs to keep dividing.
Measuring NADH Inside a Living Brain
One practical challenge with studying NADH in humans is that most measurements require tissue biopsies or blood draws, neither of which captures what is happening inside specific organs in real time. A method using phosphorus magnetic resonance spectroscopy now allows non-invasive measurement of intracellular NAD+ and NADH concentrations and their ratio directly in the living human brain.29PubMed Central. Intracellular redox state revealed by in vivo (31) P MRS measurement of NAD(+) and NADH contents in brains This technique is what made it possible to detect the redox changes caused by ketosis described earlier, and it opens a window into how diet, aging, disease, and treatments actually affect the brain’s metabolic state without requiring surgery or autopsy tissue.
The ability to track the NAD+/NADH ratio in living tissue could eventually become a clinical tool. If a physician could see that a patient’s brain or liver redox ratio was shifting in the wrong direction, it might flag metabolic dysfunction earlier than current biomarkers can. The technology is still mostly a research instrument, but the trajectory from research MRI technique to clinical application has precedent.